検索結果

cuity(1) . However, no guidelines or evidence-based therapies have been established anywhere in the world for CRAO(2) . Senju will work diligently to develop SJP-0008 as a new therapy for such a serio...

Quality Policies | About Senju | SENJU Pharmaceutical

activities according to the following policies: （Realization of products） · We seek evidence-based, world-class, and high-quality products across the entire production process from R&D to manufact...

Management Policy | About Senju | SENJU Pharmaceutical

ion（of our ideal future） To provide care that is effective for the five senses of people around the world A company that persistently creates and provides original and high-quality pharmaceutical prod...

orted questionnaire, the Dry Eye-Related Quality-of-Life Score (DEQS)*3. This achievement marks the world’s first successful clinical development of a TRPV1 antagonist for DED, completed in Japan. DED...

全球业务开展 | 海外活动 | 千寿制药株式会社

海外基地 北京代表处中国，北京 1606B，16th Floor, West Tower, World Financial Centre No.1, East 3rd Ring Middle Road, Chaoyang District, Beijing, P.R.C. Postal Code：100020 Tel：+86-10-6533-0200 Fax：+86-10-6536-1329 千寿...